#	Pagina
attuale pagina	/open-h2020/projects/196269/index.html

Opendata, web and dolomites

VETBIOMAT

Advanced material for the regeneration of joints in veterinary medicine

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

VETBIOMAT project word cloud

Explore the words cloud of the VETBIOMAT project. It provides you a very rough idea of what is the project "VETBIOMAT" about.

yield accelerating chondrocytes articular routes specialized inclusion instrument glycosaminoglycans treatment natural symptoms accomplishment unmet actually sme reducing therapies sem nutraceuticals tested oa rely nsaids regenerative migration clinical origin cartilage shown treatments marketed disease analgesics industrialized completion plan larger share dogs business standardized regeneration administered vetbiomat hr007 efficacy bovine international horses mesenchymal corticosteroids gags cells material commercial progressive administration positioning efficiency osteoarthritis scientific multiple economic sound veterinary successful superior efficacious market significantly authorization phases seek deterioration orally accomplished feasibility qualities medicine artinvet cure innovative vitro joint

Project "VETBIOMAT" data sheet

The following table provides information about the project.

Coordinator	ARTINVET INNOVATIVE THERAPIES SL Organization address address: PARQUE TECNOLOGICO DE BIZKAIA 8002º city: DERIO postcode: 48160 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Spain [ES]
Project website	http://artinvetmed.com/index.php/en/id/133-vetbiomat
Total cost	71˙429 €
EC max contribution	50˙000 € (70%)
Programme	1. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument) 2. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
Code Call	H2020-SMEINST-1-2014
Funding Scheme	SME-1
Starting year	2015
Duration (year-month-day)	from 2015-02-01 to 2015-07-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	ARTINVET INNOVATIVE THERAPIES SL ARTINVET INNOVATIVE THERAPIES SL Organization address address: PARQUE TECNOLOGICO DE BIZKAIA 8002º city: DERIO postcode: 48160 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	ES (DERIO)	coordinator	50˙000.00

Map

Project objective

The main objective of VetBiomat is to undertake a technical and market feasibility study on an innovative regenerative medicine treatment for osteoarthritis (OA) in horses and dogs based on a new advanced material, HR007. The use of this material is expected to significantly increase treatment efficiency over currently marketed products and address the unmet need of achieving a cure for this disease in horses and dogs.

Osteoarthritis, a progressive deterioration of the joint cartilage, is a major economic problem in veterinary medicine. Currently, there is no cure for OA, and therapies available rely on reducing symptoms (corticosteroids, NSAIDs, and analgesics) or on the administration of glycosaminoglycans by different routes. No sound scientific evidence of efficacy for most glycosaminoglycans based commercial treatments has yet been obtained, especially when administered orally, nutraceuticals, which actually have the largest market share. Therefore, the market potential for a new efficacious, complex, and regenerative intra-articular product of non-bovine origin is very large. ArtinVet Innovative Therapies, S.L., a new SME specialized in veterinary regenerative medicine, has a novel and unique multiple GAGs rich material of natural origin, HR007, for inclusion in new regenerative medicine based products for veterinary medicine. This advanced material has shown in vitro superior qualities to any other tested products in promoting cartilage regeneration and chondrocytes and mesenchymal cells migration. HR007 production has been standardized and industrialized.

Successful completion of Phase 1 of VetBiomat will yield a robust business plan for a much larger project that will seek funding under Phase 2 of the SEM Instrument, when clinical studies and product authorization procedures will be accomplished. Successful accomplishment of phases 1 and 2 will be essential for accelerating the growth of the SME ArtinVet and its international market positioning.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "VETBIOMAT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "VETBIOMAT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.3.1.;H2020-EU.2.1.2.)

S3D (2015)

Feasibility study to determine the use of ITS technology to replace nuclear density meters in mining, dredging and other areas of hydraulic transport.